Marina Green-Gomez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Marina Green-Gomez has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- John M. Nolan
Nutrition Research Centre Ireland, School of Health Science, South East Technological University, X91 K236 Waterford, Ireland
4 shared publications - Aldo Torre
Gastroenterology Department ABC Medical Center Mexico City Mexico
1 shared publication - Alfonso Prado-Cabrero
Nutrition Research Centre Ireland, School of Health Science, Carriganore House, Waterford Institute of Technology, West Campus, Waterford X91 K236, Ireland
1 shared publication Andrés Duarte‐Rojo
Division of Gastroenterology and Hepatology University of Arkansas for Medical Sciences (UAMS) Little Rock AR USA
1 shared publicationAstrid Ruiz‐Margáin
Liver Clinic Department of Gastroenterology Instituto Nacional de Ciencias Médicas y Nutrición “Salvador Zubirán” México D.F Tlalpan México
1 shared publicationCarlos Cantú‐Brito
Department of Neurology Instituto Nacional de Ciencias Médicas y Nutrición “Salvador Zubirán” México D.F Tlalpan México
1 shared publication
Latest Publications
- Open Access
- 18 August 2020
- Published by MDPI AG in Antioxidants
- Vol. 9 (8) , 767
The Impact of Formulation on Lutein, Zeaxanthin, and meso-Zeaxanthin Bioavailability: A Randomised Double-Blind Placebo-Controlled Study
Lutein (L), zeaxanthin (Z), and meso-zeaxanthin (MZ) have been the focus of research and commercial interest for their applications in human health. Research into formulations to enhance their bioavailability is merited. This 6 month randomised placebo-controlled trial involving 81 healthy volunteers compared the bioavailability of different formulations of free L, Z, and MZ in sunflower or omega-3 oil versus L, Z, and MZ diacetates (Ld, Zd, and MZd) in a micromicellar formulation. Fasting serum carotenoids, macular pigment, and skin carotenoid score were analysed at baseline and 6 months. Serum L, Z, and MZ concentrations increased in all active interventions compared to placebo (p < 0.001 to p = 0.008). The diacetate micromicelle formulation exhibited a significantly higher mean response in serum concentrations of Z and MZ compared to the other active interventions (p = 0.002 to 0.019). A micromicellar formulation with solubilised Z and MZ diacetates is a promising technology advancement that enhances the bioavailability of these carotenoids when compared to traditional carotenoid formulations (ISRCTN clinical trial registration number: ISRCTN18206561).
- 18 August 2020
- Published by MDPI AG in Antioxidants
- Vol. 9 (8) , 767
Open AccessThe Impact of Formulation on Lutein, Zeaxanthin, and meso-Zeaxanthin Bioavailability: A Randomised Double-Blind Placebo-Controlled Study
Lutein (L), zeaxanthin (Z), and meso-zeaxanthin (MZ) have been the focus of research and commercial interest for their applications in human health. Research into formulations to enhance their bioavailability is merited. This 6 month randomised placebo-controlled trial involving 81 healthy volunteers compared the bioavailability of different formulations of free L, Z, and MZ in sunflower or omega-3 oil versus L, Z, and MZ diacetates (Ld, Zd, and MZd) in a micromicellar formulation. Fasting serum carotenoids, macular pigment, and skin carotenoid score were analysed at baseline and 6 months. Serum L, Z, and MZ concentrations increased in all active interventions compared to placebo (p < 0.001 to p = 0.008). The diacetate micromicelle formulation exhibited a significantly higher mean response in serum concentrations of Z and MZ compared to the other active interventions (p = 0.002 to 0.019). A micromicellar formulation with solubilised Z and MZ diacetates is a promising technology advancement that enhances the bioavailability of these carotenoids when compared to traditional carotenoid formulations (ISRCTN clinical trial registration number: ISRCTN18206561).
- Open Access
- 30 July 2020
- Published by Springer Nature
The efficacy of different nutritional formulas of lutein, zeaxanthin, and meso-zeaxanthin and their impact on the human body
- 30 July 2020
- Published by Springer Nature
Open AccessThe efficacy of different nutritional formulas of lutein, zeaxanthin, and meso-zeaxanthin and their impact on the human body
- Open Access
- 1 November 2019
- Published by Association for Research in Vision and Ophthalmology (ARVO) in Translational Vision Science & Technology
- Vol. 8 (6) , 41
Standardizing the Assessment of Macular Pigment Using a Dual-Wavelength Autofluorescence Technique
Purpose: It is essential to have an appropriate measure to assess macular pigment (MP) that can provide an accurate, valid, and reliable representation of the MP within the macula. The aim of this study was to describe and introduce MP optical volume (MPOV) as an optimal value for reporting MP. Methods: Three hundred ninety-three subjects were analyzed using the Heidelberg Spectralis with the investigational MP optical density (MPOD) module to measure MPOV and MPOD at four foveal eccentricities (0.23°, 0.51°, 0.98°, 1.76° [7° as reference point]). Lutein (L) and zeaxanthin (Z) dietary intake and serum concentrations were evaluated. Results: MPOV mean was 5094 (95%CI, 4877–5310); range: 527 to 10,652. MPOV was inversely correlated with body mass index and positively correlated with education (r = −0.156, P = 0.002 and r = 0.124, P = 0.014, respectively). Serum concentrations of L and Z were positively correlated with MPOV (r = 0.422, P < 0.001 and r = 0.285, P < 0.001, respectively). MPOV was positively correlated to MPOD at all measured eccentricities, with the strongest agreement at 1.76° (r = 0.906, P < 0.001). Serum concentrations of L and Z, BMI, education, and age (P < 0.001) were found to be significant predictors of MPOV. Conclusions: The Spectralis MPOV measurement provided a comprehensive and detailed evaluation of the MP profile. The Spectralis MPOV should be considered a preferred metric for the assessment of MP. Translational Relevance: Applying a standardized method for the assessment and report of MP will allow to fully derive meaning from observational studies and to successfully implement this MP measurement technique in research and clinical settings.
- 1 November 2019
- Published by Association for Research in Vision and Ophthalmology (ARVO) in Translational Vision Science & Technology
- Vol. 8 (6) , 41
Open AccessStandardizing the Assessment of Macular Pigment Using a Dual-Wavelength Autofluorescence Technique
Purpose: It is essential to have an appropriate measure to assess macular pigment (MP) that can provide an accurate, valid, and reliable representation of the MP within the macula. The aim of this study was to describe and introduce MP optical volume (MPOV) as an optimal value for reporting MP. Methods: Three hundred ninety-three subjects were analyzed using the Heidelberg Spectralis with the investigational MP optical density (MPOD) module to measure MPOV and MPOD at four foveal eccentricities (0.23°, 0.51°, 0.98°, 1.76° [7° as reference point]). Lutein (L) and zeaxanthin (Z) dietary intake and serum concentrations were evaluated. Results: MPOV mean was 5094 (95%CI, 4877–5310); range: 527 to 10,652. MPOV was inversely correlated with body mass index and positively correlated with education (r = −0.156, P = 0.002 and r = 0.124, P = 0.014, respectively). Serum concentrations of L and Z were positively correlated with MPOV (r = 0.422, P < 0.001 and r = 0.285, P < 0.001, respectively). MPOV was positively correlated to MPOD at all measured eccentricities, with the strongest agreement at 1.76° (r = 0.906, P < 0.001). Serum concentrations of L and Z, BMI, education, and age (P < 0.001) were found to be significant predictors of MPOV. Conclusions: The Spectralis MPOV measurement provided a comprehensive and detailed evaluation of the MP profile. The Spectralis MPOV should be considered a preferred metric for the assessment of MP. Translational Relevance: Applying a standardized method for the assessment and report of MP will allow to fully derive meaning from observational studies and to successfully implement this MP measurement technique in research and clinical settings.
- 1 April 2014
- Published by Wiley in Liver International
- Vol. 35 (2) , 344-352
Cerebral haemodynamics in cirrhotic patients with hepatic encephalopathy
Background & Aims: Factors other than elevated levels of ammonia may be implicated in hepatic encephalopathy (HE) pathophysiology, including abnormal cerebral haemodynamics. Transcranial Doppler ultrasonography (TCD) evaluates cerebrovascular structural integrity and reactivity, through pulsatility index (PI) and breath‐holding index (BHI) respectively. The aim of this study was to evaluate cerebral haemodynamics by TCD in patients with compensated and decompensated cirrhosis, and patients with and without HE.Methods: We studied 90 subjects by TCD measuring PI and BHI in the middle cerebral artery: 30 with cirrhosis and no HE, 30 with cirrhosis and low‐grade HE and 30 healthy subjects. Critical flicker frequency, psychometric hepatic encephalopathy score and West‐Haven criteria were performed to assess MHE and HE respectively.Results: Pulsatility index increased in decompensated cirrhotics (Child ≥ 7) when compared with compensated cirrhotics and healthy subjects [median (IQR) 1.07 (0.95–1.21) vs 0.90 (0.83–1.05) vs 0.87 (0.78–0.96); P < 0.001]. A reverse relationship was observed for BHI among the three groups [0.82 (0.45–1.11) vs 1.20 (0.82–1.52) vs 1.28 (1.06–1.68); P < 0.001]. Similar findings were observed in decompensation [model for end‐stage liver disease (MELD) score ≥14]. Patients with HE showed higher PI and lower BHI [1.05 (1.00–1.16) and 0.89 (0.59–1.15)], when compared with patients without HE [0.96 (0.83–1.13) and 1.00 (0.60–1.53)] or controls [0.87 (0.78–0.96) and 1.28 (1.06–1.68)] (P < 0.001 for PI, and P = 0.007 for BHI). In multivariate regression models, only PI predicted HE, but it was outperformed by MELD‐sodium and tumour necrosis factor‐alpha.Conclusions: These results indicate that cerebral haemodynamics are altered in patients with cirrhosis, in relation to severity of disease and HE. Findings on impaired PI and BHI suggest that structural vascular damage and loss of vascular autoregulation are implicated in the pathophysiology of HE.
- 1 April 2014
- Published by Wiley in Liver International
- Vol. 35 (2) , 344-352
Cerebral haemodynamics in cirrhotic patients with hepatic encephalopathy
Background & Aims: Factors other than elevated levels of ammonia may be implicated in hepatic encephalopathy (HE) pathophysiology, including abnormal cerebral haemodynamics. Transcranial Doppler ultrasonography (TCD) evaluates cerebrovascular structural integrity and reactivity, through pulsatility index (PI) and breath‐holding index (BHI) respectively. The aim of this study was to evaluate cerebral haemodynamics by TCD in patients with compensated and decompensated cirrhosis, and patients with and without HE.Methods: We studied 90 subjects by TCD measuring PI and BHI in the middle cerebral artery: 30 with cirrhosis and no HE, 30 with cirrhosis and low‐grade HE and 30 healthy subjects. Critical flicker frequency, psychometric hepatic encephalopathy score and West‐Haven criteria were performed to assess MHE and HE respectively.Results: Pulsatility index increased in decompensated cirrhotics (Child ≥ 7) when compared with compensated cirrhotics and healthy subjects [median (IQR) 1.07 (0.95–1.21) vs 0.90 (0.83–1.05) vs 0.87 (0.78–0.96); P < 0.001]. A reverse relationship was observed for BHI among the three groups [0.82 (0.45–1.11) vs 1.20 (0.82–1.52) vs 1.28 (1.06–1.68); P < 0.001]. Similar findings were observed in decompensation [model for end‐stage liver disease (MELD) score ≥14]. Patients with HE showed higher PI and lower BHI [1.05 (1.00–1.16) and 0.89 (0.59–1.15)], when compared with patients without HE [0.96 (0.83–1.13) and 1.00 (0.60–1.53)] or controls [0.87 (0.78–0.96) and 1.28 (1.06–1.68)] (P < 0.001 for PI, and P = 0.007 for BHI). In multivariate regression models, only PI predicted HE, but it was outperformed by MELD‐sodium and tumour necrosis factor‐alpha.Conclusions: These results indicate that cerebral haemodynamics are altered in patients with cirrhosis, in relation to severity of disease and HE. Findings on impaired PI and BHI suggest that structural vascular damage and loss of vascular autoregulation are implicated in the pathophysiology of HE.